Diabetes Clinical Research Program
The Diabetes Clinical Research Program at Benaroya Research Institute is an international leader in Type 1 (autoimmune) diabetes research. The program's goal is to help families with Type 1 diabetes by investigating ways to prevent diabetes, finding new approaches of diagnosing the disease in its earliest stage to optimize the potential for successful treatment, and testing innovative new therapies.
Type 1 Diabetes Trialnet, Northwest Clinical Center
The Diabetes Clinical Research Program at Benaroya Research Institute is the Type 1 Diabetes TrialNet Northwest Clinical Center. TrialNet is a network of 18 clinical centers located worldwide. As the Northwest Clinical Center, the Diabetes Program coordinates with sites in Washinton, Idaho, Oregon, Montana and Alaska to conduct prevention research for persons at risk for Type 1 diabetes and to study intervention therapies for children and adults with newly diagnosed diabetes. The TrialNet clinical centers are working toward the goal of screening 200,000 relatives of persons with Type 1 diabetes to determine their risk and to increase scientific knowledge about Type 1 diabetes. Individuals found to be at risk will be closely monitored and may be eligible for prevention trials. www.diabetestrialnet.org.
Immune Tolerance Network, Clinical Center
The Diabetes Clinical Research Program is a member of the Immune Tolerance Network (ITN), a collaborative research effort aimed at inducing, maintaining and monitoring tolerance in humans, for kidney, liver and islet transplantation, autoimmune diseases and allergy and asthma. We are currently conducting studies aimed at preserving insulin secretion in patients newly diagnosed with Type 1 diabetes. www.immunetolerance.org.
Type 1 Diabetes Genetics Consortium, North American Coordinating Center
The Diabetes Clinical Research Program serves as the North American Network Coordinating Center for Type 1 Diabetes Genetics Consortium (T1DGC). T1DGC researchers are trying to understand how the difference in the genes we inherit contribute to the risk of developing Type 1 diabetes. As the North American Coordinating Center, the Diabetes Clinical Research Program is responsible for bringing diabetes researchers together from throughout the U.S. and Canada to collect samples from families with at least two full siblings with Type 1 diabetes. Additionally, T1DGC researchers are also collecting samples from African-American and Mexican American individuals, where Type 1 diabetes is not as prevalent. www.t1dgc.org.
JDRF-BRI Center for Translational Research
The Diabetes Research Program is designated as the Juvenile Diabetes Research Foundation (JDRF) Center for Translational Research. The goal is to combine the clinical, metabolic, genetic and immune information from persons with Type 1 diabetes and their family members to better understand the Type 1 diabetes disease process.
To look for clinical research trials for diabetes.